SEPARATION AND IDENTIFICATION OF PHASE-I AND PHASE-II [(1)4C]ANTIPYRINE METABOLITES IN RAT AND DOG URINE

被引:12
|
作者
VELIC, I
METZLER, M
HEGE, HG
WEYMANN, J
机构
[1] KNOLL AG,DEPT BIOCHEM,D-67061 LUDWIGSHAFEN,GERMANY
[2] UNIV KAISERSLAUTERN,D-67663 KAISERSLAUTERN,GERMANY
来源
关键词
D O I
10.1016/0378-4347(94)00552-G
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and accurate HPLC procedure was developed to quantify, in a single run, all phase I and phase II [C-14]antipyrine metabolites that occur in rat and dog urine. All metabolites were subjected to thermospray-LC-MS and EI-MS in order to establish their structure. The rat metabolizes antipyrine to eight major metabolites, six of which are conjugated; 1.4% of the dose was excreted unchanged, 18.9% in a free form, 30.6% as sulfates and 21.1% as glucuronides. The dog metabolizes antipyrine to four metabolites, all as sulfate (61.0% of the dose) or glucuronide conjugates (16.2% of the dose).
引用
收藏
页码:139 / 147
页数:9
相关论文
共 50 条
  • [1] PHASE-I AND PHASE-II METABOLITES OF BENZTROPINE IN RAT URINE AND BILE
    HE, H
    MCKAY, G
    MIDHA, KK
    XENOBIOTICA, 1995, 25 (08) : 857 - 872
  • [2] IDENTIFICATION OF PHASE-I AND PHASE-II METABOLITES OF FLUPHENAZINE IN RAT BILE - INTACT GLUCURONIDE AND SULFATE CONJUGATES
    JACKSON, CJC
    HUBBARD, JW
    MCKAY, G
    COOPER, JK
    HAWES, EM
    MIDHA, KK
    DRUG METABOLISM AND DISPOSITION, 1991, 19 (01) : 188 - 193
  • [3] PHARMACOLOGICAL EFFECTS OF PHASE-I AND PHASE-II METABOLITES OF TRIAMTERENE
    KNAUF, H
    MUTSCHLER, E
    VOLGER, KD
    WAIS, U
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1978, 28-2 (08): : 1417 - 1420
  • [4] DIURETIC ACTIVITY OF PHASE-I AND PHASE-II METABOLITES OF TRIAMTERENE
    ALBIEZ, G
    KNAUF, H
    MUTSCHLER, E
    VOLGER, KD
    WAIS, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 : R36 - R36
  • [5] GENERATION OF PHASE-I AND PHASE-II OF MIGRATING MYOELECTRIC COMPLEX IN THE DOG
    LANG, IM
    SARNA, SK
    CONDON, RE
    AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (02): : G201 - G207
  • [6] PHASE-I AND PHASE-II STUDIES OF VINDESINE
    VALDIVIESO, M
    CANCER TREATMENT REVIEWS, 1980, 7 : 31 - 37
  • [7] PIRARUBICIN (PHASE-I AND PHASE-II TESTS)
    MATHE, G
    UMEZAWA, H
    BRIENZA, S
    TAPIERO, H
    DANTCHEV, D
    MARINO, JP
    GASTIABURU, J
    DEVASSAL, F
    MISSET, JL
    RIBAUD, P
    MUSSET, M
    DESPAX, R
    BURKI, F
    GOLDSCHMIDT, E
    BULLETIN DU CANCER, 1988, 75 (07) : 618 - 618
  • [8] ANALYSIS OF PHASE-I AND PHASE-II METABOLITES OF TAMOXIFEN IN BREAST-CANCER PATIENTS
    POON, GK
    CHUI, YC
    MCCAGUE, R
    LONNING, PE
    FENG, R
    ROWLANDS, MG
    JARMAN, M
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (06) : 1119 - 1124
  • [9] EFFECTS OF DIMETHYLSULFOXIDE ON PHASE-I AND PHASE-II BIOTRANSFORMATION IN CULTURED RAT HEPATOCYTES
    ROGIERS, V
    VANDENBERGHE, Y
    CALLAERTS, A
    SONCK, W
    VERCRUYSSE, A
    TOXICOLOGY IN VITRO, 1990, 4 (4-5) : 439 - 442
  • [10] PHASE-I AND PRELIMINARY PHASE-II STUDY OF NEOCARZINOSTATIN
    GRIFFIN, TW
    COMIS, RL
    LOKICH, JJ
    BLUM, RH
    CANELLOS, GP
    CANCER TREATMENT REPORTS, 1978, 62 (12): : 2019 - 2025